Specific Dietary Pattern for Crohn's Disease Patients Following Surgery
Effectiveness and Pathogenesis of Specific Dietary Pattern in Maintaining Remission Among Crohn's Disease(CD) Patients Following Surgery
1 other identifier
interventional
35
1 country
1
Brief Summary
Over the past 10 years, there are a large number of dietary treatments related to the CD, such as specific carbohydrate diet, low Fermentable Oligo-, Di-, Mono-saccharides And Polyols (FODMAP) diet, and allergen-free foods. But there is no consistent conclusion or convincing evidence about the effectiveness. Through the long-term clinical experience observation, we find most of the CD patients can get stable remission by removing refined food and intolerance food.This project aims at developing a new dietary therapy suitable for Chinese patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2022
CompletedFirst Posted
Study publicly available on registry
August 16, 2022
CompletedStudy Start
First participant enrolled
September 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
February 2, 2026
January 1, 2026
3.8 years
August 11, 2022
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of Life(IBDQ)
IBDQ: Inflammatory Bowel Disease Questionnaire.The IBDQ evaluates the quality of life of patients from four aspects: intestinal symptoms, systemic symptoms, emotional function and social function. There are 32 questions in the questionnaire, with a total score of 32 to 224 points. The higher the score, the higher the quality of life of the patient.
The two groups of patients were scored at first week and sixth week after surgery.
Secondary Outcomes (2)
nutritional status of the patient
The two groups were evaluated at first week and sixth week after surgery.
Disease-related evaluation indicators
The two groups were evaluated at first week and sixth week after surgery.
Other Outcomes (1)
dietary compliance
The two groups were evaluated at sixth week after surgery.
Study Arms (2)
Exclusive Enteral Nutrition(EEN)
ACTIVE COMPARATORSubjects required exclusive enteral nutrition for one month
Specific Diet+ Partial Enteral Nutrition
EXPERIMENTALSubjects received partial enteral nutrition with remaining energy and nutrients obtained through diet for one month
Interventions
Reprocessed and intolerant foods were removed from the dietary pattern, and the food were cooked at home for experimental subjects.
All energy and nutrients are obtained from exclusive enteral nutrition.
Eligibility Criteria
You may qualify if:
- Diagnose CD according to endoscopy, histology and imaging;
- Bowel resection for CD
- Oral nutritional preparations or food can be given after surgery
You may not qualify if:
- Plan operation within 5 weeks after surgery;
- Presence of an ileostomy or colostomy
- Complete bowel obstruction or fibrous stricture
- Pregnancy or breastfeeding;
- Plan to use biological agents within 5 weeks after surgery;
- Plan to use corticosteroids or prednisone greater than 20 mg per day or equivalent doses of drugs to maintain remission within 5 weeks after surgery;
- Plan to use probiotics or prebiotics for more than 1 week after surgery;
- Antibiotics are used for more than 2 weeks after surgery;
- Hypersensitivity to known components of enteral nutrition;
- BMI less than 14 or greater than 28 kg/m2;
- Celiac disease;
- Complicated with other autoimmune diseases such as diabetes or rheumatic disease, autoimmune liver disease, psoriasis;
- Mental illness;
- Malignant tumors
- Those who are not suitable for body composition analysis (such as pacemakers and metal objects in the body)
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310009, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
yu qiao
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
- STUDY DIRECTOR
guo huilan
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2022
First Posted
August 16, 2022
Study Start
September 17, 2022
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
February 2, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share